Report Detail

Pharma & Healthcare Global (United States, European Union and China) Dry Eye Syndrome Market Research Report 2019-2025

  • RnM3669878
  • |
  • 14 August, 2019
  • |
  • Global
  • |
  • 117 pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Global (United States, European Union and China) Dry Eye Syndrome Market Research Report 2019-2025

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Dry Eye Syndrome Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Prescription drugs
      • 1.3.3 Over-the-counter (OTC) drugs
    • 1.4 Market Segment by Application
      • 1.4.1 Global Dry Eye Syndrome Market Share by Application (2019-2025)
      • 1.4.2 Hospitals and Clinics
      • 1.4.3 Medical Laboratories
      • 1.4.4 Others
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Dry Eye Syndrome Market Size
      • 2.1.1 Global Dry Eye Syndrome Revenue 2014-2025
      • 2.1.2 Global Dry Eye Syndrome Sales 2014-2025
    • 2.2 Dry Eye Syndrome Growth Rate by Regions
      • 2.2.1 Global Dry Eye Syndrome Sales by Regions 2014-2019
      • 2.2.2 Global Dry Eye Syndrome Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Dry Eye Syndrome Sales by Manufacturers
      • 3.1.1 Dry Eye Syndrome Sales by Manufacturers 2014-2019
      • 3.1.2 Dry Eye Syndrome Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Dry Eye Syndrome Revenue by Manufacturers (2014-2019)
      • 3.2.2 Dry Eye Syndrome Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Dry Eye Syndrome Market Concentration Ratio (CR5 and HHI)
    • 3.3 Dry Eye Syndrome Price by Manufacturers
    • 3.4 Key Manufacturers Dry Eye Syndrome Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Dry Eye Syndrome Market
    • 3.6 Key Manufacturers Dry Eye Syndrome Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Prescription drugs Sales and Revenue (2014-2019)
      • 4.1.2 Over-the-counter (OTC) drugs Sales and Revenue (2014-2019)
    • 4.2 Global Dry Eye Syndrome Sales Market Share by Type
    • 4.3 Global Dry Eye Syndrome Revenue Market Share by Type
    • 4.4 Dry Eye Syndrome Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Dry Eye Syndrome Sales by Application

    6 United States

    • 6.1 United States Dry Eye Syndrome Breakdown Data by Company
    • 6.2 United States Dry Eye Syndrome Breakdown Data by Type
    • 6.3 United States Dry Eye Syndrome Breakdown Data by Application

    7 European Union

    • 7.1 European Union Dry Eye Syndrome Breakdown Data by Company
    • 7.2 European Union Dry Eye Syndrome Breakdown Data by Type
    • 7.3 European Union Dry Eye Syndrome Breakdown Data by Application

    8 China

    • 8.1 China Dry Eye Syndrome Breakdown Data by Company
    • 8.2 China Dry Eye Syndrome Breakdown Data by Type
    • 8.3 China Dry Eye Syndrome Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Dry Eye Syndrome Breakdown Data by Company
    • 9.2 Rest of World Dry Eye Syndrome Breakdown Data by Type
    • 9.3 Rest of World Dry Eye Syndrome Breakdown Data by Application
    • 9.4 Rest of World Dry Eye Syndrome Breakdown Data by Countries
      • 9.4.1 Rest of World Dry Eye Syndrome Sales by Countries
      • 9.4.2 Rest of World Dry Eye Syndrome Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Allergan
      • 10.1.1 Allergan Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Dry Eye Syndrome
      • 10.1.4 Dry Eye Syndrome Product Introduction
      • 10.1.5 Allergan Recent Development
    • 10.2 Novartis
      • 10.2.1 Novartis Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Dry Eye Syndrome
      • 10.2.4 Dry Eye Syndrome Product Introduction
      • 10.2.5 Novartis Recent Development
    • 10.3 Otsuka Holdings
      • 10.3.1 Otsuka Holdings Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Dry Eye Syndrome
      • 10.3.4 Dry Eye Syndrome Product Introduction
      • 10.3.5 Otsuka Holdings Recent Development
    • 10.4 Santen Pharmaceutical
      • 10.4.1 Santen Pharmaceutical Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Dry Eye Syndrome
      • 10.4.4 Dry Eye Syndrome Product Introduction
      • 10.4.5 Santen Pharmaceutical Recent Development
    • 10.5 Aerie Pharmaceutical
      • 10.5.1 Aerie Pharmaceutical Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Dry Eye Syndrome
      • 10.5.4 Dry Eye Syndrome Product Introduction
      • 10.5.5 Aerie Pharmaceutical Recent Development
    • 10.6 Akorn
      • 10.6.1 Akorn Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Dry Eye Syndrome
      • 10.6.4 Dry Eye Syndrome Product Introduction
      • 10.6.5 Akorn Recent Development
    • 10.7 Bausch & Lomb
      • 10.7.1 Bausch & Lomb Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Dry Eye Syndrome
      • 10.7.4 Dry Eye Syndrome Product Introduction
      • 10.7.5 Bausch & Lomb Recent Development
    • 10.8 Johnson & Johnson
      • 10.8.1 Johnson & Johnson Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Dry Eye Syndrome
      • 10.8.4 Dry Eye Syndrome Product Introduction
      • 10.8.5 Johnson & Johnson Recent Development
    • 10.9 Merck
      • 10.9.1 Merck Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Dry Eye Syndrome
      • 10.9.4 Dry Eye Syndrome Product Introduction
      • 10.9.5 Merck Recent Development
    • 10.10 MIMETOGEN
      • 10.10.1 MIMETOGEN Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Dry Eye Syndrome
      • 10.10.4 Dry Eye Syndrome Product Introduction
      • 10.10.5 MIMETOGEN Recent Development
    • 10.11 ReGenTree
    • 10.12 Sun Pharmaceutical
    • 10.13 Teva Pharmaceutical

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Dry Eye Syndrome Sales Channels
      • 11.2.2 Dry Eye Syndrome Distributors
    • 11.3 Dry Eye Syndrome Customers

    12 Market Forecast

    • 12.1 Global Dry Eye Syndrome Sales and Revenue Forecast 2019-2025
    • 12.2 Global Dry Eye Syndrome Sales Forecast by Type
    • 12.3 Global Dry Eye Syndrome Sales Forecast by Application
    • 12.4 Dry Eye Syndrome Forecast by Regions
      • 12.4.1 Global Dry Eye Syndrome Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Dry Eye Syndrome Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Dry eye syndrome, also known as keratoconjunctivitis sicca, is the condition of having dry eyes where either the eyes are not capable of producing sufficient tears to maintain lubrication or the when produced, they evaporate too quickly. The condition can lead to various difficulties in the daily life of a person, such as reading for an extended period of time or using a computer. The condition can decrease the tolerance of a person in a dry environment such as air present inside an airplane.
      Dry eye syndrome is gaining prominence due to the changing lifestyles, consumption of specified medicines, and increased rate of diseases. Autoimmune diseases, genetic factors, environmental conditions, and routine practices such as extended usage of contact lenses and prolonged computer usage also cause dry eye syndrome.
      The dry eye syndrome drugs market is moderately populated owing to the presence of few key vendors competing intensely with smaller vendors. Vendors in the dry eye medication market compete based on the long-term efficacy of the drugs with minimum side effects. Dry eye syndrome drug manufacturers cater extensively to hospitals and pharmacies.
      In 2019, the market size of Dry Eye Syndrome is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Dry Eye Syndrome.

      This report studies the global market size of Dry Eye Syndrome, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Dry Eye Syndrome sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Allergan
      Novartis
      Otsuka Holdings
      Santen Pharmaceutical
      Aerie Pharmaceutical
      Akorn
      Bausch & Lomb
      Johnson & Johnson
      Merck
      MIMETOGEN
      ReGenTree
      Sun Pharmaceutical
      Teva Pharmaceutical

      Market Segment by Product Type
      Prescription drugs
      Over-the-counter (OTC) drugs

      Market Segment by Application
      Hospitals and Clinics
      Medical Laboratories
      Others

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Dry Eye Syndrome status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Dry Eye Syndrome manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Dry Eye Syndrome are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025


      Summary:
      Get latest Market Research Reports on Dry Eye Syndrome. Industry analysis & Market Report on Dry Eye Syndrome is a syndicated market report, published as Global (United States, European Union and China) Dry Eye Syndrome Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Dry Eye Syndrome market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,280.00
      $4,920.00
      $6,560.00
      2,693.54
      4,040.30
      5,387.07
      2,957.78
      4,436.66
      5,915.55
      349,306.88
      523,960.32
      698,613.76
      235,310.15
      352,965.23
      470,620.30
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report